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Abstract
Background: CHARGE syndrome is a complex of birth defects including coloboma, choanal
atresia, ear malformations and deafness, cardiac defects, and growth delay. We have previously
hypothesized that CHARGE syndrome could be caused by unidentified genomic microdeletion, but
no such deletion was detected using short tandem repeat (STR) markers spaced an average of 5
cM apart. Recently, microdeletion at 8q12 locus was reported in two patients with CHARGE,
although point mutation in CHD7 on chromosome 8 was the underlying etiology in most of the
affected patients.
Methods: We have extended our previous study by employing a much higher density of SNP
markers (3258) with an average spacing of approximately 800 kb. These SNP markers are diallelic
and, therefore, have much different properties for detection of deletions than STRs.
Results: A global error rate estimate was produced based on Mendelian inconsistency. One
marker, rs431722 exceeded the expected frequency of inconsistencies, but no deletion could be
demonstrated after retesting the 4 inconsistent pedigrees with local flanking markers or by FISH
with the corresponding BAC clone. Expected deletion detection (EDD) was used to assess the
coverage of specific intervals over the genome by deriving the probability of detecting a common
loss of heterozygosity event over each genomic interval. This analysis estimated the fraction of
unobserved deletions, taking into account the allele frequencies at the SNPs, the known marker
spacing and sample size.
Conclusions: The results of our genotyping indicate that more than 35% of the genome is included
in regions with very low probability of a deletion of at least 2 Mb.
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Background
CHARGE Association is characterized by ocular colo-
boma, cranial nerve abnormalities, common outflow tract
heart defects, choanal atresia, cupped-shaped pinnae,
Mondini dysplasia of the inner ear [1,2] and growth delay.
The embryology and mechanisms of maldevelopment in
CHARGE are not well understood. CHARGE Association
may be genetically heterogeneous, a possibility supported
by the rare and variable chromosomal aberrations
observed in a few affected individuals. We have identified
a de novo mutation in a semaphorin gene, SEMA3E, in an
affected patient, identified upon mapping the transloca-
tion breakpoints in an unrelated individual with a de novo
balanced translocation involving chromosomes 2 and 7:
karyotype 46, XY, t(2;7)(p14;q21.11) [3]. Recently, Viss-
ers et al. have reported mutations in CHD7 gene, a mem-
ber of the chromodomain family in a substantial number
of patients [4]. In a large number of children, however, the
genetic mechanism of this complex birth defect remains
unidentified. Graham has suggested that a subgroup of
children with CHARGE Association have a recognizable
syndrome [5] and may have a common pathologic and
molecular basis. We have focused our study in this subset
of patients and hypothesized that within this group, there
is a common chromosomal region where recombination
events lead to frequent microdeletion. In a previous study
we used short tandem repeat (STR) markers spaced at an
average of 5 cM to examine ten CHARGE case-parent trios
for a large common deletion [6]. STR markers, because
they are multi-allelic, generally are highly informative in
each trio and there is little ambiguity regarding Mendelian
transmission of parental alleles. The study did not identify
any common deletion, but it was limited because of the
relatively broad marker spacing. We have now extended
the analysis by genotyping 3258 diallelic SNP markers
with an average spacing of approximately 800 kb, in the
same nuclear families. If microdeletion is the underlying
basis of this disorder, then genotyping using this dense set
of SNPs would be expected to uncover loci with loss of
expected heterozygosity in the probands. We have taken
into account the major and minor allele frequencies of
each of the 3258 SNP markers and used a metric called the
expected deletion detection, EDD [Belmont et al., per-
sonal communication] to evaluate specific chromosomal
intervals for the probability of detecting a deletion in the
sample set. Although no deletion was detected in the
CHARGE study sample, we conclude that this method
could be generally useful in other studies in which small
deletions occur as part of the allelic spectrum of disease.
Methods
Patients
The diagnosis of CHARGE syndrome was established by
examination by a participating clinical genetics specialist
(CB, JWB, SRL). A medical history questionnaire was com-
pleted by the parents or by direct interview. For the core
genotyping, 8 Caucasian and 1 Hispanic case/parent trios
were selected based on the presence of 4 major criteria or
three major and three minor criteria for the syndrome [7].
There were five affected males and four affected females,
with ages ranging from five to twenty years. Blood was col-
lected and transformed cell lines were established for
these families. This research protocol was reviewed and
approved by the Baylor College of Medicine Institutional
Review Board.
Genotyping
Genotyping for this study was carried out on an Orchid
BioSciences SNPstream UHT platform (Princeton, NJ) as
previously described [8]. For this study, an initial set of
~4,200 T/C SNPs were identified and selected from the
public databases for incorporation into a genome wide
SNP panel. After selection, the complete set of SNPs was
arranged into ~350 unique 12-plex reactions for the pur-
pose of performing the assays on the UHT platform. The
complete set of markers was then validated on a set of 5
CEPH pedigrees (40 individuals) and in 3 independent
populations. A final set of 3258 markers was chosen from
these combined datasets for analysis after eliminating
SNPs that performed poorly through all populations,
SNPs that failed both Hardy-Weinberg and Mendelian
error calculations and any SNPs that were not polymor-
phic in the evaluated populations. An average genome
wide spacing of ~800 kb between markers was achieved
for this panel.
This genotyping method utilized Orchid's single base
primer extension chemistry (SBE) to identify which bases
were present at the site of interrogation. Multiplexed reac-
tions (12-plex) were performed in a single tube that incor-
porated labeled chain terminating nucleotides onto the
ends of the SBE oligonucleotides. These reactions were
then hybridized onto a microarray format, that facilitates
the solid-phase sorting of the labeled extension-primers to
a set of universal tagged primers arrayed on the surface of
the plate. The universal tags were arranged on the surface
of the microarray plate in a 384-well microwell layout.
This microarray format created a generic design consisting
of 384 4 × 4 arrays that contained 12 oligonucleotides that
corresponded to 12 unique universal capture tags. The
four additional oligonucleotides, plotted in each array,
were used for positive and negative controls. Genotyping
calls were determined by the presence or absence of incor-
porated dyes that appeared at each spot on the printed
arrays.
TaqMan polymerase chain reaction
Two Assays-on-demand SNPs, rs422951 and ss1309424,
flanking rs431722 were obtained from Applied Biosys-
tems and genotyping was performed in 384 well-plates,BMC Medical Genetics 2005, 6:8 http://www.biomedcentral.com/1471-2350/6/8
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using the TaqMan polymerase chain reaction-based
method. The final volume reaction was 5 µl using 12 ng of
genomic DNA, 2.5 µl of Taqman Master mix and 0.25 µl
of 20X Assays-on-Demand SNP Genotyping Assay Mix.
The plate was heated at 95° for 10 minutes, followed by
forty cycles of denaturation at 92° for 15 seconds and
annealing/extension at 60° for 1 minute. PCR plates were
read on ABI PRISM 7900HT instrument with SDS v2.0
software. Individual genotypes that were ambiguous were
excluded.
Fish
Bacterial Artificial chromosomes (BACs) were selected
from the public database [9] and obtained from Chil-
dren's Hospital Oakland Research Institute. DNA extrac-
tion was performed according to the standard protocol.
Fluorescence  in situ hybridization was performed as
described elsewhere [6]. Detection of the digoxigenin
labeled probe was performed with anti-digoxigenin con-
jugated to rhodamine, giving a red signal. Biotin labeled
control probe was detected with FITC (fluorescein isothi-
ocyanate), giving a green signal. The chromosomes were
counterstained with DAPI and analyzed with a Zeiss Axi-
oskop fluorescence microscope equipped with appropri-
ate filter combinations. Approximately 10 metaphase
preparations were scored for each hybridization.
Data analysis
The genotype error rate was estimated using the method
of Gordon et al. [10] and as implemented in CUE [11].
Expected deletion detection (EDD) is a new method
designed for this study, which uses the allele frequency,
the marker spacing and the number of pedigrees sampled
to estimate the probability that a common deletion would
be missed because of ambiguous genotype outcomes.
Qualitatively, the information available in a single SNP
marker for the purposes of detecting a deletion by lack of
expected heterozygosity in a case-parent trio is limited by
the many genotype configurations that could appear con-
sistent with Mendelian inheritance, but actually harbor a
deletion. Inclusion of 2 or more SNP markers in a deletion
interval decreases the likelihood that a common deletion
goes undetected.
Results
SNP genotyping data were subjected to analysis for Hardy-
Weinberg equilibrium. As an additional test of marker
integrity, a transmission disequilibrium test was also per-
formed for each of the SNP markers to examine for distor-
tions in allele transmission in the trios. Unequal
transmission of alleles from the heterozygote parents to
the affected offspring was not determined by this analysis.
Non-paternity was excluded in core pedigrees. Using the
method of Gordon [12], we used the genotyping data to
estimate the genotyping error rate at 0.02%. Analysis of
the data showed transmission inconsistent with Mende-
lian inheritance for 22 markers on different chromosomes
(20 with 1 inconsistency, 1 with 2 inconsistencies, and 1
with 4 inconsistencies). Given the underlying genotyping
error rate, we could predict that markers with >2 incon-
sistencies would be highly unlikely to occur. One marker,
rs431722 with overall call rate of 95%, showed Mende-
lian inconsistency in 4 trios. This SNP was found to lie
within the intron 2 of the NOTCH4 gene on chromosome
6p21.32. Human DNA sequence from clone XXbac-
300A18 (GenBank accession number AL662884) on
chromosome 6p21 was used for FISH. This BAC clone
encompasses the NOTCH4 gene, and was confirmed by
PCR amplification of the clone sequence using NOTCH4
specific primers (data not shown). The analysis of the
metaphase chromosomes after staining with DAPI
showed two bright hybridization signals, indicating the
presence of both alleles (Figure 1). Two additional SNPs,
rs422951 and ss1309424, flanking rs431722 within 780
bp, were genotyped using TaqMan chemistry. The results
showed inheritance of biparental alleles in all four pedi-
grees. The CHD7 locus on 8q12 was investigated addi-
tionally with FISH using RP11-33I11 (GenBank accession
number AC113143) and RP11-414L17 (GenBank acces-
sion number AC023102). Using these BAC clones, micro-
deletion of this region was excluded in all the affected
patients in this study sample.
Because none of the pedigrees were consanguineous, we
used parental data to estimate the allele frequencies for
each of the 3258 SNP markers [13]. The EDD was then
calculated for each chromosome. The percent coverage
ranged from 51% on chromosome 20 to 20% on chromo-
some 15, with a mean of 36% for an autosomal deletion
of 2 Mb (Figure 2).
Discussion
Despite various efforts to understand the molecular basis
of CHARGE syndrome, with candidate genes sequencing
[14,15], comparative genomic hybridization [16], and
genome-wide scan for microdeletion(s) using microsatel-
lite markers [6], the underlying molecular mechanism in
many patients remained unknown until recently [4].
Based on the complex phenotype and clinical overlap
with Velocardiofacial syndrome, it is a plausible hypothe-
sis that in a subset of CHARGE patients with a homoge-
nous phenotype, the underlying genetic mechanism is a
cryptic submicroscopic deletion involving highly pleio-
tropic gene(s). To address this hypothesis, we had previ-
ously used microsatellite markers to ascertain loci with
loss of expected heterozygosity in case-parent trios. SNPs
are far more abundant than microsatellite markers but
have not yet been used extensively in linkage and loss of
heterozygosity (LOH) studies. The present study repre-
sents the application of SNPs to scan for potentialBMC Medical Genetics 2005, 6:8 http://www.biomedcentral.com/1471-2350/6/8
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submicroscopic deletions across the autosomes. Amos et
al. have previously shown that SNP genotyping of child-
parent trios provides valuable information about the pres-
ence of de novo microdeletion when sufficient families are
studied [17]. However, this method is most appropriate
when linkage disequilibrium is accounted for because of
high SNP marker density. They have provided a general
analytical framework and point out the effects of non-
paternity, sample mix-up, and genotyping error in the
interpretation of Mendelian inconsistency in case-parent
trio data with biallelic markers. As expected, increases in
rates of such phenomenon in the data decrease power to
detect a microdeletion. In addition, they point out that
heterogeneity in the position of a putative deletion also
has a large impact on power. Their analysis is particularly
apt given the probable future availability of extremely
high density SNP marker maps and the technical capabil-
ity to genotype hundreds of thousands of markers per
FISH analysis of NOTCH4 gene Figure 1
FISH analysis of NOTCH4 gene. Two copies of the locus on 6p21.32 using XXbac-300A18 clone.BMC Medical Genetics 2005, 6:8 http://www.biomedcentral.com/1471-2350/6/8
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research subject. However, they do not explore the effect
of intermarker distance in the ability to detect deletions of
various sizes.
Assuming the genotyping error rate of 0.5%, the probabil-
ity of observing >2 inconsistencies per marker is very low.
The SNP marker rs431722 showed Mendelian inconsist-
ency in four of nine pedigrees, with apparent loss of a
parental allele in each case i.e. a frequency much higher
than expected for the genotyping error rate. Interestingly,
this SNP is located within the NOTCH4 gene on chromo-
some 6p21.32. The Notch gene family encodes highly
conserved transmembrane receptors that are involved in
intercellular signaling. The Notch signaling pathway plays
an essential role in regulating embryonic vascular mor-
phogenesis and remodeling [18]. Moreover, disruption of
Deletion coverage Figure 2
Deletion coverage. Chromosome-specific maps indicating the Expected Deletion Detection over each interval.BMC Medical Genetics 2005, 6:8 http://www.biomedcentral.com/1471-2350/6/8
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Notch signaling via mutation in the Notch ligand JAG1 is
known to result in Alagille syndrome [19], nonsyndromic
Tetralogy of Fallot (TOF) [20] and possibly nonsyndromic
biliary extrahepatic atresia [21]. Since TOF is a heart defect
commonly seen in CHARGE Syndrome, NOTCH4  was
further studied with FISH as well as flanking SNP markers
for microdeletion. The results, however conclusively
excluded a discernible microdeletion at this locus.
This screen is expected to detect deletions of about 1–2
Mb depending on the overlap of the SNP markers with the
deletion interval. Variable coverage for each chromosome
was determined for approximately 2 Mb microdeletion in
this study. Almost 50% of chromosomes 7, 19 and 20
were excluded for any microdeletion greater than 2 Mb.
The least coverage was observed for chromosome 15 and
18, with exclusion of 20% of the chromosome for the
presence of a similar genetic aberration. Overall, we can
estimate that approximately 36% of the genome had
>80% chance for detecting a common 2 Mb deletion in at
least 2 patients with CHARGE Syndrome.
There are several limitations to this approach in studying
the genetics of CHARGE syndrome. Although the marker
density is high, the reduced amount of information per
marker means that only some of the trios give the possi-
bility of a conclusive result. Denser marker sets would be
predicted to fill most of the gaps, but the regions around
the centromeres are likely to be difficult with any currently
available technique.
The strategy out lined in this paper would work equally
well for conventional Mendelian traits in which the
mutant alleles included at least some deletions. Using a
much denser SNP map of 1 marker every 5–10 kb, as is
anticipated for whole genome association analyses, it
would be possible to detect most deletions given a suffi-
cient representation of deletions within the spectrum of
gene mutations.
Conclusions
In this report we show that a SNP genotyping screen has
excluded moderate length submicroscopic deletions in a
subset of patients with CHARGE syndrome. Further anal-
ysis by microarray comparative genome hybridization
methods or denser SNPs will allow a comprehensive
assessment of the role, if any, of microdeletions in
CHARGE syndrome.
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